Venous thromboembolism
Conditions
Interventions
Pharmacist intervention group:On the basis of standard nursing care, the anticoagulant medication management for patients was carried out through the online platform of the Alfalfa APP
Standard Nursing Group:Anticoagulant medication management was carried out for patients through routine standard care
Sponsors
Fujian Maternity and Child Health Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1: Age >= 18 years old. 2: Suspected or diagnosed as malignant tumors of the female reproductive organs, not specifically specified. 3: Gynecological malignant tumor surgery is planned to be performed during the hospitalization. 4: Anticoagulant therapy lasts for at least 28 days. 5: Receive anticoagulant drug management through the Alfalfa APP or regular standard care. 6: The patient has no communication and interaction barriers and can cooperate with regular follow-up examinations as required. 7: Agree to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1: The hospital's electronic medical record system retrieves information related to cognitive impairment or mental disorders. 2: Severe liver dysfunction (total bilirubin higher than twice the upper limit of normal, and AST/ALT/ALP higher than three times the upper limit of normal). 3: Severe renal insufficiency (endogenous creatinine clearance rate =30mL/min). 4: People with thrombotic diseases. 5: Long-term use of non-steroidal anti-inflammatory drugs. 6: Patients diagnosed with benign gynecological tumors during the operation. 7: Pregnancy or breastfeeding. 8: Patients with contraindications to anticoagulation (with risks of active bleeding, liver failure, blood diseases or contraindicated bleeding, and contraindications to the use of anticoagulants). 9: Uncontrolled severe hypertension (systolic blood pressure >200 mm Hg or diastolic blood pressure >120 mm Hg). 10: One of the following uncontrolled or unstable cardiovascular diseases exists: stroke, acute ischemia or myocardial infarction confirmed by electrocardiogram, and/or clinically significant arrhythmia. 11: Use artificial heart valves. 12: The physician believes that participating in the trial is not in the best interests of the patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anticoagulation cognitive questionnaire score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Venous thromboembolism;Medication satisfaction;Medication compliance; | — |
Countries
China
Contacts
Public ContactTing Wei
Fujian Maternity and Child Health Hospital
Outcome results
None listed